The purpose of this study is to evaluate a new drug (BIIB017) for the treatment of pediatric patients with Relapsing Remitting Multiple Sclerosis. This drug is already used to treat adults with MS.
There are two parts to this study. Everyone participating will be in Part 1, and you may also choose to be in Part 2. For Part 1, you will have one visit to determine if you are eligible, and 11 clinic visits. You will have an MRI at 4 of the 11 clinic visits. You will also have 2 phone calls. If you choose to participate in part 2, you will visit the clinic 8 times, have one follow-up visit, and you may have another MRI.
Reimbursement will be provided for travel, meals, and lodging expenses, if needed
Irena Dujmovic Basuroski
Clinical or Medical
Brain, Head, Nervous System
Child and Teen Health